The value of glial fibrillary acidic protein levels in the diagnosis and prognosis of subarachnoid hemorrhage
Authors:
Open Access
- 1 May 2022
- journal article
- research article
- Published by Wiley in Hong Kong Journal of Emergency Medicine
- Vol. 29 (3) , 151-160
Abstract
Background: Subarachnoid hemorrhages is an important emergency condition due to its high morbidity and mortality. Early diagnosis and rapid intervention are very important to prevent poor clinical outcome of this disease.Objective: The aim of this study was to determine the value of glial fibrillary acidic protein in the diagnosis and prognosis of subarachnoid hemorrhage.Methods: Patients presenting to the emergency department and undergoing computerized tomography and/or lumbar puncture due to suspicion of subarachnoid hemorrhage were included in this prospective study. Based on the computerized tomography–lumbar puncture results, cases were divided into subarachnoid hemorrhage group and non–subarachnoid hemorrhage control group. Subarachnoid hemorrhage patients were classified on the basis of severity of subarachnoid hemorrhage and were classified as good or poor clinical outcome groups based on Glasgow Outcome Scores. Glial fibrillary acidic protein levels were then compared.Results: A total of 111 patients were evaluated due to suspicion of subarachnoid hemorrhage and diagnosed with subarachnoid hemorrhage (n = 73) or without subarachnoid hemorrhage (n = 38). Cerebrospinal fluid glial fibrillary acidic protein levels were significantly higher in the subarachnoid hemorrhage group than in the non–subarachnoid hemorrhage group (p < 0.001) (median (25%–75%): 11.62 (2.64–68.04) and 2.26 (1.5–4.83), respectively). Serum glial fibrillary acidic protein levels of the subarachnoid hemorrhage patients with poor clinical outcomes were higher than those of subarachnoid hemorrhage patients with good clinical outcomes (p = 0.003) and cerebrospinal fluid glial fibrillary acidic protein levels were similar (p = 0.379). Glial fibrillary acidic protein levels at the time of presentation exhibited a low level of correlation with Glasgow coma score, World Federation of Neurological Surgeons scale, Hunter–Hess Scale, Ogilvy–Carter Scale, Glasgow Outcome Score, and modified Rankin score.Conclusion: Cerebrospinal fluid glial fibrillary acidic protein levels may be a valuable diagnostic parameter at the time of presentation for diagnosis of subarachnoid hemorrhage. And also serum glial fibrillary acidic protein levels may be useful in predicting subarachnoid hemorrhage patients with poor clinical outcomes.Keywords
This publication has 22 references indexed in Scilit:
- Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain InjuryJAMA Neurology, 2016
- Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort studyCritical Care, 2015
- Guía de actuación clínica en la hemorragia subaracnoidea. Sistemática diagnóstica y tratamientoNeurología, 2014
- Biomarkers of vasospasm development and outcome in aneurysmal subarachnoid hemorrhageJournal of the Neurological Sciences, 2014
- Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological DiseasesPLOS ONE, 2013
- Guidelines for the Management of Aneurysmal Subarachnoid HemorrhageStroke, 2012
- Serum Glial Fibrillary Acidic Protein Is Related to Focal Brain Injury and Outcome After Aneurysmal Subarachnoid HemorrhageStroke, 2007
- Increased GFAP and S100β but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severityEuropean Journal of Neurology, 2006
- Initial Misdiagnosis and Outcome After Subarachnoid HemorrhageJAMA, 2004
- Serum- and CSF-concentrations of brain specific proteins in hydrocephalusActa Neurochirurgica, 2003